K. Harzer

6.1k total citations
167 papers, 4.5k citations indexed

About

K. Harzer is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, K. Harzer has authored 167 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Physiology, 76 papers in Molecular Biology and 42 papers in Organic Chemistry. Recurrent topics in K. Harzer's work include Lysosomal Storage Disorders Research (116 papers), Carbohydrate Chemistry and Synthesis (41 papers) and Cellular transport and secretion (27 papers). K. Harzer is often cited by papers focused on Lysosomal Storage Disorders Research (116 papers), Carbohydrate Chemistry and Synthesis (41 papers) and Cellular transport and secretion (27 papers). K. Harzer collaborates with scholars based in Germany, United States and France. K. Harzer's co-authors include Konrad Sandhoff, Barbara C. Paton, B. Kustermann‐Kuhn, Horst Jatzkewitz, A. Poulos, Wolfgang Roggendorf, M. Elleder, F. Šmíd, Arndt Rolfs and Andreas Klein and has published in prestigious journals such as Cell, The Lancet and Journal of Biological Chemistry.

In The Last Decade

K. Harzer

163 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Harzer Germany 34 3.1k 2.2k 1.2k 816 785 167 4.5k
Peter G. Pentchev United States 43 4.6k 1.5× 2.6k 1.2× 1.4k 1.2× 713 0.9× 1.6k 2.0× 111 6.7k
Jan‐Eric Månsson Sweden 43 2.1k 0.7× 2.8k 1.3× 1.1k 0.9× 572 0.7× 518 0.7× 157 5.4k
John W. Callahan Canada 34 1.8k 0.6× 1.8k 0.8× 1.1k 0.9× 425 0.5× 417 0.5× 125 3.9k
Xingxuan He United States 34 2.0k 0.6× 2.4k 1.1× 939 0.8× 588 0.7× 377 0.5× 63 4.3k
Katsumi Higaki Japan 34 1.8k 0.6× 1.6k 0.7× 787 0.6× 628 0.8× 987 1.3× 102 3.3k
Gideon Bach Israel 35 1.6k 0.5× 1.2k 0.6× 1.0k 0.8× 538 0.7× 442 0.6× 113 3.9k
Anu Jalanko Finland 35 2.0k 0.6× 2.1k 1.0× 1.4k 1.1× 377 0.5× 195 0.2× 88 3.8k
Alexey V. Pshezhetsky Canada 46 1.5k 0.5× 3.0k 1.4× 1.2k 1.0× 763 0.9× 588 0.7× 127 5.0k
Jaana Tyynelä Finland 31 1.7k 0.5× 1.4k 0.7× 1.1k 0.9× 349 0.4× 121 0.2× 63 3.1k
Alessandro Fraldi Italy 25 1.6k 0.5× 1.9k 0.9× 1.1k 0.9× 1.6k 2.0× 132 0.2× 39 4.4k

Countries citing papers authored by K. Harzer

Since Specialization
Citations

This map shows the geographic impact of K. Harzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Harzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Harzer more than expected).

Fields of papers citing papers by K. Harzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Harzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Harzer. The network helps show where K. Harzer may publish in the future.

Co-authorship network of co-authors of K. Harzer

This figure shows the co-authorship network connecting the top 25 collaborators of K. Harzer. A scholar is included among the top collaborators of K. Harzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Harzer. K. Harzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ribeiro, Isaura, et al.. (2013). Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: Identification of the first large deletion in ASAH1 gene. Molecular Genetics and Metabolism. 109(3). 276–281. 18 indexed citations
2.
Sandhoff, Konrad & K. Harzer. (2013). Gangliosides and Gangliosidoses: Principles of Molecular and Metabolic Pathogenesis. Journal of Neuroscience. 33(25). 10195–10208. 198 indexed citations
3.
Kuchař, Ladislav, J. Ledvinová, Martin Hřebı́ček, et al.. (2009). Prosaposin deficiency and saposin B deficiency (activator‐deficient metachromatic leukodystrophy): Report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations. American Journal of Medical Genetics Part A. 149A(4). 613–621. 60 indexed citations
4.
Rolfs, Arndt, Tobias Böttcher, Peter J. Morris, et al.. (2005). Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. The Lancet. 366(9499). 1794–1796. 321 indexed citations
6.
Harzer, K., Masao Hiraiwa, & Barbara C. Paton. (2001). Saposins (sap) A and C activate the degradation of galactosylsphingosine. FEBS Letters. 508(1). 107–110. 20 indexed citations
7.
Burek, Małgorzata, Johannes Roth, Hans-Georg Koch, et al.. (2001). The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells. Oncogene. 20(45). 6493–6502. 35 indexed citations
9.
Grassmé, Heike, Erich Gulbins, Birgit Brenner, et al.. (1997). Acidic Sphingomyelinase Mediates Entry of N. gonorrhoeae into Nonphagocytic Cells. Cell. 91(5). 605–615. 263 indexed citations
10.
Levade, Thierry, Maria Tempesta, H. W. Moser, et al.. (1995). Sulfatide and Sphingomyelin Loading of Living Cells as Tools for the Study of Ceramide Turnover by Lysosomal Ceramidase - Implications for the Diagnosis of Farber-Disease. Biochemical and Molecular Medicine. 54(2). 117–125. 7 indexed citations
11.
Elleder, M., H. Christomanou, B. Kustermann‐Kuhn, & K. Harzer. (1994). Leptomeningeal lipid storage patterns in Fabry disease. Acta Neuropathologica. 88(6). 579–582. 4 indexed citations
12.
Molzer, Brunhilde, F. Gullotta, K. Harzer, A. Poulos, & H. Bernheimer. (1993). Unusual orthochromatic leukodystrophy with epitheloid cells (Norman-Gullotta): increase of very long chain fatty acids in brain discloses a peroxisomal disorder. Acta Neuropathologica. 86(2). 187–189. 1 indexed citations
13.
Šmíd, F., et al.. (1993). Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Human Genetics. 92(2). 143–152. 107 indexed citations
14.
Harzer, K., et al.. (1990). Immunocytochemical localization of sphingolipid activator protein 2 (SAP-2) in normal and SAP-deficient fibroblasts.. PubMed. 51(1). 157–64. 27 indexed citations
15.
Harzer, K., Barbara C. Paton, A. Poulos, et al.. (1989). Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: Biochemical signs of combined sphingolipidoses. European Journal of Pediatrics. 149(1). 31–39. 163 indexed citations
16.
Harzer, K., et al.. (1981). Zur Diagnostik der metachromatischen Leukodystrophie durch Arylsulfatase-A-Bestimmung im Blut: Genetische Studie der Normalwerte an 64 Mutter-Kind-Paaren. European Archives of Psychiatry and Clinical Neuroscience. 229(4). 291–304. 1 indexed citations
17.
Harzer, K.. (1979). [Prenatal diagnosis of incurable familial metabolic diseases. Prenatal diagnosis of disorders of lipid metabolism].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(48). 1810–6. 1 indexed citations
18.
Harzer, K., et al.. (1977). Very low arylsulfatase A and cerebroside sulfatase activities in leukocytes of healthy members of metachromatic leukodystrophy family.. Library Stack (Library Stack). 29(2). 191–4. 71 indexed citations
19.
Harzer, K., et al.. (1976). [Observations on the course of juvenile metachromatic leukodystrophy].. PubMed. 47(2). 103–7. 4 indexed citations
20.
Régli, F, et al.. (1974). Metachromatische Leukodystrophie: Genetische Studie einer familiren adulten Form der metachromatischen Leukodystrophie (MLD). 219(4). 369–375. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026